Pharma · Private company

Chiesi Farmaceutici S.p.A.

Track this companyFree. Adds Chiesi Farmaceutici S.p.A. to your Dealase workspace and tells you when its record changes.

Clinical trials258 recruiting or active

Pipeline programs28From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline28

AlteplasePhase 3 · Catheter OcclusionClinicalTrials.gov · fetched Nov 12, 2026
Beclomethasone DipropionatePhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
Beclomethasone DipropionatePhase 3 · COPDClinicalTrials.gov · fetched Nov 12, 2026
Beclomethasone Dipropionate/Formoterol FumaratePhase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
CHF6001 1600µgPhase 3 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
CHF6001 3200µgPhase 3 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Curosurf through conventional administration (endotracheal tube)Phase 3 · Respiratory Distress Syndrome (RDS)ClinicalTrials.gov · fetched Nov 12, 2026
CUSA-081Phase 3 · Catheter OcclusionClinicalTrials.gov · fetched Nov 12, 2026
Experimental: CHF6001 1600µgPhase 3 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Experimental: CHF6001 3200µgPhase 3 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Formoterol FumaratePhase 3 · COPDClinicalTrials.gov · fetched Nov 12, 2026
Glycopyrronium BromidePhase 3 · COPDClinicalTrials.gov · fetched Nov 12, 2026
LISA combination product (Curosurf+catheter CHF6440)Phase 3 · Respiratory Distress Syndrome (RDS)ClinicalTrials.gov · fetched Nov 12, 2026
metreleptinPhase 3 · Partial LipodystrophyClinicalTrials.gov · fetched Nov 12, 2026
MetreleptinPhase 3 · Familial Partial LipodystrophyClinicalTrials.gov · fetched Nov 12, 2026
pegunigalsidase alfaPhase 3 · Fabry DiseaseClinicalTrials.gov · fetched Nov 12, 2026
PRX-102 1 mg/kg every two weeksPhase 3 · Fabry DiseaseClinicalTrials.gov · fetched Nov 12, 2026
RoflumilastPhase 3 · Chronic Obstructive Pulmonary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
CHF10067Phase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
CHF5259Phase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
CHF5993Phase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
Moxifloxacin 400mgPhase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
clevidipinePediatric Perioperative Blood Pressure ManagementClinicalTrials.gov · fetched Nov 12, 2026
elapegademase-lvlrAdenosine Deaminase Severe Combined ImmunodeficiencyClinicalTrials.gov · fetched Nov 12, 2026
FilsuvezEpidermolysis Bullosa, DystrophicClinicalTrials.gov · fetched Nov 12, 2026
MetreleptinGeneralised LipodystrophyClinicalTrials.gov · fetched Nov 12, 2026
Not applicable- observational studyFabry DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Velmanase AlfaAlpha-MannosidosisClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary FibrosisPHASE2 · RECRUITING · started Jul 8, 2026ClinicalTrials.gov NCT07516951 · fetched Nov 12, 2026
Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)PHASE3 · SUSPENDED · started Feb 1, 2026ClinicalTrials.gov NCT07181382 · fetched Nov 12, 2026
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry DiseasePHASE2_PHASE3 · RECRUITING · started Jul 29, 2025ClinicalTrials.gov NCT06328608 · fetched Nov 12, 2026
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and BreastfeedingRECRUITING · started May 23, 2025ClinicalTrials.gov NCT06941025 · fetched Nov 12, 2026
Analysis of Velmanase Alfa (Lamzede®)'s Effects in the Body of Children With Alpha-Mannosidosis Under the Age 3RECRUITING · started Feb 19, 2025ClinicalTrials.gov NCT06184503 · fetched Nov 12, 2026
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving FilsuvezRECRUITING · started Dec 18, 2024ClinicalTrials.gov NCT06423573 · fetched Nov 12, 2026
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry PatientsRECRUITING · started Nov 6, 2024ClinicalTrials.gov NCT06663358 · fetched Nov 12, 2026
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial LipodystrophyPHASE3 · RECRUITING · started Oct 14, 2024ClinicalTrials.gov NCT06679270 · fetched Nov 12, 2026
A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)PHASE1 · COMPLETED · started Mar 29, 2023ClinicalTrials.gov NCT05830071 · fetched Nov 12, 2026
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled CorticosteroidPHASE3 · COMPLETED · started Aug 31, 2022ClinicalTrials.gov NCT05292586 · fetched Nov 12, 2026
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDPHASE3 · COMPLETED · started Apr 27, 2022ClinicalTrials.gov NCT04320342 · fetched Nov 12, 2026
Premedication for Less Invasive Surfactant Administration Study (PRELISA)PHASE4 · COMPLETED · started Apr 6, 2022ClinicalTrials.gov NCT05065424 · fetched Nov 12, 2026
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PLPHASE3 · COMPLETED · started Dec 17, 2021ClinicalTrials.gov NCT05164341 · fetched Nov 12, 2026
A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)PHASE3 · TERMINATED · started Jul 14, 2021ClinicalTrials.gov NCT04636801 · fetched Nov 12, 2026
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)PHASE3 · TERMINATED · started Jul 12, 2021ClinicalTrials.gov NCT04636814 · fetched Nov 12, 2026
A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Through Less Invasive Surfactant Administration (LISA) and Conventional AdministrationPHASE3 · TERMINATED · started May 18, 2021ClinicalTrials.gov NCT02772081 · fetched Nov 12, 2026
Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) FunctionalityPHASE3 · TERMINATED · started Feb 12, 2020ClinicalTrials.gov NCT03594175 · fetched Nov 12, 2026
Registry Study of Revcovi Treatment in Patients With ADA-SCIDCOMPLETED · started Sep 30, 2019ClinicalTrials.gov NCT03878069 · fetched Nov 12, 2026
Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease PatientsPHASE3 · COMPLETED · started Nov 13, 2018ClinicalTrials.gov NCT03614234 · fetched Nov 12, 2026
Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry DiseasePHASE3 · COMPLETED · started Sep 16, 2018ClinicalTrials.gov NCT03566017 · fetched Nov 12, 2026
MEASuRE: Metreleptin Effectiveness And Safety RegistryRECRUITING · started Oct 11, 2016ClinicalTrials.gov NCT02325674 · fetched Nov 12, 2026
National Cardiogenic Shock InitiativeCOMPLETED · started May 19, 2016ClinicalTrials.gov NCT03677180 · fetched Nov 12, 2026
AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS)COMPLETED · started Jun 30, 2014ClinicalTrials.gov NCT02123667 · fetched Nov 12, 2026
Assessment of Efficacy, Safety and Dosing of Clevidipine in Pediatric Participants Undergoing Surgery (PIONEER)PHASE4 · TERMINATED · started Mar 17, 2014ClinicalTrials.gov NCT01938547 · fetched Nov 12, 2026
Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease PatientsAPPROVED_FOR_MARKETINGClinicalTrials.gov NCT04552691 · fetched Nov 12, 2026